Back

Effectiveness and safety of continued oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate risk: a nationwide propensity score weighted-cohort study

26 August 2017 (14:24 - 14:42)
Organised by:
Congress Presentation Part of: After pulmonary embolism: optimising treatment and follow up Acute pulmonary embolism ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Soeren Paaske Johnsen

Department of Clinical Medicine, Aalborg (Denmark)

4 More presentations in this session

Presentation thumbnail
State of the Art: acute treatment of pulmonary embolism
Professor N. Kucher (Zurich, CH)
Slides Video
Presentation thumbnail
Determinants of the long-term haemodynamic course and late sequelae after acute intermediate-risk pulmonary embolism: results from a randomized thrombolysis trial
Doctor S. Barco (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Validation of the VTE-BLEED score for predicting 30-day major bleeding in a real-world cohort of patients with pulmonary embolism
Mr K. Kresoja (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Selecting the optimal duration and regimen of anticoagulation after pulmonary embolism
Professor S. Konstantinides (Mainz, DE)
Slides Video

Access the full session

Session thumbnail
After pulmonary embolism: optimising treatment and follow up

The Event

Event poster

ESC Congress 2017

26 August 2017 14:24 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources